Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Galera Therapeutics Inc shares valued at $25,650 were purchased by Schneid Yair on Feb 08 ’24. At $0.17 per share, Schneid Yair acquired 150,000 shares. The insider’s holdings grew to 8,043,203 shares worth approximately $1.53 million following the completion of this transaction.
Also, Schneid Yair purchased 175,000 shares, netting a total of over 30,185 in proceeds. Following the buying of shares at $0.17 each, the insider now holds 7,893,203 shares.
Before that, Schneid Yair had added 25,000 shares to its account. In a trade valued at $5,025, the 10% Owner bought Galera Therapeutics Inc shares for $0.20 each. Upon closing the transaction, the insider’s holdings increased to 25,000 shares, worth approximately $1.47 million.
As published in a research note from Piper Sandler on August 10, 2023, Galera Therapeutics Inc [GRTX] has been rated down from an Overweight to a Neutral and the price target has been revised to $0.50 from $6. Analysts at BTIG Research downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in mid October. As of October 19, 2021, BofA Securities has decreased its “Buy” rating to a “an Underperform” for GRTX.
Analyzing GRTX Stock Performance
During the last five days, there has been a surge of approximately 16.18%. Over the course of the year, Galera Therapeutics Inc shares have jumped approximately 27.92%. Shares of the company reached a 52-week high of $0.2900 on 02/28/24 and a 52-week low of $0.1314 on 03/28/24. A 50-day SMA is recorded $0.1963, while a 200-day SMA reached $0.4969. Nevertheless, trading volume fell to 3.77 million shares from 3.82 million shares the previous day.
Support And Resistance Levels for Galera Therapeutics Inc (GRTX)
According to the 24-hour chart, there is a support level at 0.1670, which, if violated, would cause prices to drop to 0.1480. In the upper region, resistance lies at 0.2095. The next price resistance is at 0.2330. RSI (Relative Strength Index) is 51.55 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0198, which suggests the price will decrease in the coming days. Percent R is at 56.33%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
